Latest Camurus News & Updates

See the latest news and media coverage for Camurus. We track all announcements, press releases, and industry mentions in real time, all in one place.

Camurus

Swedish biopharmaceutical company developing long-acting medicines

camurus.com

Headquarters: Lund, Sweden
Founded year: 1991
Company type: Public company
Number of employees: 250–500

Last updated Today

Latest news about Camurus

In short: Camurus secured major strategic collaborations and European drug approvals but faced a notable 2027 delay for its hormonal disorder drug in the US.

Company announcements

June 10 Camurus

Camurus updates on regulatory process for CAM2029 in the USA

FDA issued a request for additional information regarding the application for marketing approval for CAM2029 (Oclaiz) for acromegaly.

June 1 Camurus

Camurus announces expanded collaboration with Lilly

Lilly exercises option for amylin agonists. Camurus receives up to 870 million USD in milestone payments.

May 12 Camurus

Camurus publishes interim report for Q1 2026

Revenues decreased 5% and FDA accepted application for Oclaiz.

April 29 Camurus

Camurus announces annual report for 2025 available

The annual report is available on the website in ESEF format. During 2025, growth, increased profitability and progress in the portfolio were achieved. Sustainability report is included.

Media coverage

June 11 Reuters

Camurus' hormone disorder drug expected to be approved in 2027 after fresh FDA setback

Wall Street has pushed to next year expectations for a U.S. approval for Camurus' drug to treat a rare hormonal condition after the health ‌regulator's...

May 12 Yahoo Finance

Camurus AB (CAMRF) Q1 2026 Earnings Call Highlights: Strong Revenue Growth...

This article first appeared on GuruFocus. Release Date: May 12, 2026 For the complete transcript of the earnings call, please refer to the full earnings...

May 12 Dagens industri

Banks lift the stock of the report loser: "Attractive case"

Nordea and Handelsbanken choose to look past yesterday's report miss from Camurus, which sent the stock down 8.8 percent. The analyses make the price to...

March 27 Affärsvärlden

Handelsbanken lowers the target price for Camurus to 600 kronor (700), repeats hold

By signing up for the free subscription Affärsvärlden Free, you get a selection of all our material, as well as a daily newsletter with the latest news.

Never miss news about Camurus

Track Camurus and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Camurus competitors & trending companies

Browse news for competitors to Camurus and other trending companies.